Sooma Medical announced today that it received FDA investigational device exemption (IDE) for its transcranial direct current stimulation (tDCS) device.
New research from the University of Kentucky has earned a spot on the cover of the Journal of Neuroscience, highlighting a major challenge in spinal cord injury recovery.
Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and successfully eliminated 50% of the tumors in model animals. This study was led by Dr. Razan Masarwy, MD, Ph.D. from the lab of Prof. Dan Peer. The findings are published in the journal Advanced Science.
Researchers at the Francis Crick Institute have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells.
Miach Orthopaedics announced today that the FDA cleared an expanded indication for the company’s Bear implant for ACL tears.
Lungpacer Medical announced today that it received FDA investigational device exemption (IDE) to begin a trial for its AeroNova system.
The findings provide new drug targets for stopping the infection’s spread.
Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the University of Wisconsin–Madison have been at the forefront of stem cell research and regenerative biology since James Thomson isolated the first human embryonic stem cell in 1998.
BREA, Calif., March 10, 2025 /PRNewswire/ — Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k) clearance from the U.S. Food and Drug Administration. The DxC 500i combines advanced technology with an intuitive user interface, ensuring that laboratories of all sizes can meet the growing demands of modern healthcare. With throughput of up to 800 clinical chemistry tests per hour and 100 immunoassay tests per hour, this analyzer delivers precise and reliable results critical for timely clinical decision-making.
Exactech this week announced the first surgical procedures using its Vantage Ankle 3D and 3D+ tibial implants with GPS Ankle navigation.